Physician profile
Christopher J Ricks
NPI 1255727905
$795.49
in general payments reported to CMS, 2019-2025
13 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2021: $26.79 · 2022: $35.43 · 2023: $233 · 2024: $189 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $212.84 | 2019-2025 | Clareon, Clareon Panoptix Pro |
| Carl Zeiss Meditec USA, INC. | $171.97 | 2023 | Iolmaster 700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $97.79 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $89.74 | 2024 | Tecnis Iol |
| Novartis Pharmaceuticals Corporation | $54.60 | 2022-2023 | |
| Dompe US, INC. | $34.24 | 2024 | Oxervate |
| Rxsight INC | $26.79 | 2021 | |
| Mallinckrodt Hospital Products INC. | $25.91 | 2023 | Acthar |
| Genentech USA, INC. | $21.56 | 2024 | Vabysmo |
| Sun Pharmaceutical Industries INC. | $16.23 | 2023 | Cequa |
| Abbvie INC. | $16.16 | 2024 | |
| Bausch & Lomb Americas INC. | $13.89 | 2024 | Vyzulta |
| Tarsus Pharmaceuticals, INC. | $13.77 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.